TICKERNERD
Menu
CLVTCLVTTechnology · Information Technology Services

CLVT Stock Forecast: Clarivate Plc Price Predictions for 2026-2027

Last close, 21 Aug 2026
$2.09
+0.72% on the day

The 8 Wall Street analysts covering Clarivate Plc hold a median 12-month price target of $2.55 — +22.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 64 of 100 as at 22 Aug 2026 — in the upper half.

Market cap
$1.3B
Ticker Nerd rank
64 / 100
Median analyst target
$2.55
Analysts covering
8
Total return, dividends reinvested
1W
+8.0%
1M
−7.3%
YTD
−37.6%
1Y
−52.6%
From 52W high
−53.7%
From 52W low
+24.1%
$1.68
$4.50
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CLVT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Clarivate Plc on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
64 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
97
Accruals
91
Value
86
Revisions
51
Quality
50
Growth
43
Size
42
Volatility
32
Momentum
13

Issuance (97): The share count has been shrinking and the company is not leaning on new borrowing.

Momentum (13): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CLVT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CLVT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$2.00$3.00$4.00$5.00$6.00Oct 25Jan 26Apr 26Jul 26CLVTHigh $5.50Median $2.55Low $2.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says8 analysts
2 Buy5 Hold1 Sell
Low $2.00Median $2.55High $5.50

The green dot is the last close — the median target sits +22.3% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 1 moved their price target up and 4 moved it down.

DateFirmActionRatingTarget
30 July 2026BarclaysMaintainsUnderweight$2.50 → $2.00
30 July 2026CitigroupMaintainsNeutral$2.80 → $2.50
30 July 2026Goldman SachsMaintainsNeutral$2.90 → $2.60
30 July 2026StifelMaintainsBuy$6.00 → $5.00
7 July 2026BarclaysMaintainsUnderweight—
7 July 2026BarclaysMaintainsUnderweight$2.40 → $2.50
4 Mar 2026CitigroupMaintainsNeutral—
25 Feb 2026BarclaysMaintainsUnderweight—
25 Feb 2026RBC CapitalMaintainsSector Perform—
8 Jan 2026Goldman SachsDowngradeNeutral—
17 Dec 2025Morgan StanleyDowngradeUnderweight—
3 Sept 2025Wolfe ResearchInitiatesPeer Perform—
18 July 2025JefferiesDowngradeHold—
20 Feb 2025RBC CapitalReiteratesSector Perform—
7 Nov 2024BarclaysMaintainsUnderweight—
7 Nov 2024RBC CapitalMaintainsSector Perform—
6 Nov 2024William BlairDowngradeMarket Perform—
7 Aug 2024BarclaysMaintainsUnderweight—
7 Aug 2024RBC CapitalMaintainsSector Perform—
9 May 2024Goldman SachsMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CLVT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

CLVT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−2.6%
Analysts raising
2
Analysts cutting
1
Fundamentals

Clarivate Plc (CLVT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
30.8×

Cheaper than 26% of US stocks

Price / sales
0.6×

Cheaper than 81% of US stocks

Price / book
0.3×

Cheaper than 88% of US stocks

EV / EBITDA
5.9×

Cheaper than 52% of US stocks

Growth & margins
Revenue growth (YoY)
−5.5%

Higher than 19% of US stocks

Earnings growth (YoY)
−5.5%

Higher than 29% of US stocks

Gross margin
68.4%

Higher than 81% of US stocks

Operating margin
6.1%

Higher than 57% of US stocks

Net margin
−13.8%

Higher than 18% of US stocks

Returns & dividend
Return on equity
−7.0%

Higher than 38% of US stocks

Return on assets
0.9%

Higher than 49% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

CLVT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelInformation Technology Services
CompanyMarket capTKN rank
CLVTClarivate Plc$1.3B
64
MGRTMega Fortune Co., Ltd.$1.3B
16
EFOREverforth, Inc.$1.4B
62
BBAIBigBear.ai Holdings, Inc.$1.5B
12
CNXCConcentrix Corp.$1.6B
49
VYXNCR Voyix Corp.$1.1B
79
GLOBGlobant SA$1.7B
52

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Clarivate Plc — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CLVT news & analysis

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

PRNewsWire · 6 Aug 2026positive

Clarivate announced the expansion of agentic AI capabilities across its Cortellis portfolio, embedding AI into existing workflows to help life sciences R&D teams accelerate discovery, strengthen safety assessment, and make faster portfolio decisions.

Why it matters — The expansion signals Clarivate advancing AI features within its core life sciences product line, potentially strengthening the value of its Cortellis offering for customers.

Clarivate Q2 Earnings Call Highlights

MarketBeat · 29 July 2026positive

Clarivate stated in its Q2 earnings call that it expects organic recurring revenue and annualized contract value growth to improve in the second half of the year, citing renewal visibility, product momentum, and a growing pipeline of AI-enabled offerings.

Why it matters — A CLVT watcher would care because the company's own guidance suggests a turnaround in key recurring revenue and contract value metrics, which are central to its growth story.

Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript

Seeking Alpha · 29 July 2026neutral

Seeking Alpha published the transcript of Clarivate's Q2 2026 earnings call, covering the company's quarterly financial discussion with analysts.

Why it matters — The earnings call transcript provides CLVT watchers with direct commentary from management on the company's quarterly performance and outlook.

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research · 29 July 2026neutral

Clarivate reported its Q2 earnings for the quarter ended June 2026. The article suggests comparing the company's key metrics to Wall Street estimates and year-ago actuals.

Why it matters — CLVT watchers would care because the earnings report provides data on how the company performed relative to analyst expectations and its own past results.

Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates

Zacks Investment Research · 29 July 2026positive

Clarivate PLC reported Q2 earnings of $0.19 per share, exceeding the Zacks Consensus Estimate of $0.17 per share and up from $0.18 per share in the same quarter last year. Revenue also beat estimates.

Why it matters — The earnings beat suggests the company is performing better than analysts expected, which could influence investor perception of Clarivate's near-term financial health.

FAQ

Frequently asked questions about CLVT stock

What is the CLVT stock price forecast for 2026-2027?

The 8 Wall Street analysts covering Clarivate Plc have a median 12-month price target of $2.55, with estimates ranging from $2 to $5.5. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CLVT stock a buy right now?

Of the 8 analysts covering Clarivate Plc, 2 rate it a Buy, 5 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Clarivate Plc 64 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CLVT?

As at 22 Aug 2026, Clarivate Plc ranks 64 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (97 of 100).

Will CLVT stock go up?

No one can know that. What the data says: the median 12-month target from 8 analysts implies +22.3% from the last close, and Ticker Nerd's factor model ranks Clarivate Plc 64 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CLVT stock forecast for 2030?

No analyst covering Clarivate Plc publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLVT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $2 to $5.5 over the next 12 months.

How has CLVT stock performed over the past year?

Clarivate Plc returned -52.6% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Clarivate Plc do?

Clarivate Plc is a global information services and analytics company, recognized for providing comprehensive intellectual property and scientific information solutions. Its primary function is to deliver valuable insights that help businesses, researchers, and academic institutions make informed decisions by leveraging high-quality data and analytics.

What is the latest news on CLVT?

The most recent item we track (PRNewsWire, 6 Aug 2026): "Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development". Clarivate announced the expansion of agentic AI capabilities across its Cortellis portfolio, embedding AI into existing workflows to help life sciences R&D teams accelerate discovery, strengthen safety assessment, and make faster portfolio decisions.

Company

About Clarivate Plc.

Clarivate Plc is a global information services and analytics company, recognized for providing comprehensive intellectual property and scientific information solutions. Its primary function is to deliver valuable insights that help businesses, researchers, and academic institutions make informed decisions by leveraging high-quality data and analytics. The company serves a broad spectrum of sectors, including the legal, pharmaceutical, biotechnology, academic, and financial industries, facilitating advancements in research, commercialization, and innovation. Among its notable offerings are the Web of Science, a premier research database; and Derwent, a renowned source for patent information. Clarivate plays a critical role in the market by helping organizations navigate complex information ecosystems, enabling them to enhance productivity, protect and grow intellectual assets, and accelerate the pace of innovation. The company operates in an increasingly data-driven world, positioning itself as a key enabler of advancements in technology, healthcare, and scientific research.

CEO Mr. Matitiahu Shem Tov · 12,000 employees · United Kingdom · https://www.clarivate.com